The Courier-Mail

Cancer drug gives hope


A BREAKTHROU­GH drug being trialled in Australia has seen more than a third of terminally ill patients with rare blood cancer go into full remission.

Of the 15 St Vincent’s Hospital multiple myeloma patients granted access to the wonder-drug Daratumuma­b, five have already entered full remission – and many of the others more recently added to the trial are expected to soon join them as they progress.

“The response I have had in my patients has been astounding,” St Vincent’s haematolog­ist Hang Quach said from Melbourne.

“By the second cycle (eight weeks), virtually every one of my patients has gone to partial response; and by the third or fourth cycle, a lot of them are already in complete response.”

Newspapers in English

Newspapers from Australia